Subcutaneous apomorphine
Alternative Names: Apokyn®
Subcutaneous apomorphine (Apokyn®) is a fast-acting dopamine agonist used as a rescue treatment for sudden “off” episodes in Parkinson’s disease. It is injected under the skin and can improve movement within minutes, though the benefit is short-lived. This makes it useful in advanced disease when standard medications wear off unpredictably. Side effects may include nausea, vomiting, low blood pressure, sleepiness, and injection site reactions, so patients often start with an anti-nausea medication. While not used as a daily maintenance drug, it provides an important option for quick symptom relief.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: N/A
Review Summary
Based on the provided information, there are no user reviews available for the treatment "Subcutaneous apomorphine" for Parkinson's Disease. Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment from the given data. More information and user experiences are needed to assess the efficacy of Subcutaneous apomorphine in managing Parkinson's Disease symptoms.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
AI Summary of User Experiences
Not medical advice.
Based on the provided information, there are no user reviews available for the treatment "Subcutaneous apomorphine" for Parkinson's Disease. Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment from the given data. More information and user experiences are needed to assess the efficacy of Subcutaneous apomorphine in managing Parkinson's Disease symptoms.
Reviews
Filter by reviewer type Pro